PedAM
Pediatric Disease Annotations & Medicines
| Disease | gastric cancer |
| Symptom | C0346989|peritoneal metastases |
| Sentences | 13 |
| PubMedID- 24475196 | Analysis of clinical tissue samples from peritoneal metastases arising from gastric cancers provides evidence that runx3 expression decreased significantly in the metastatic tissue, compared to normal gastric mucosa or primary main tumors. |
| PubMedID- 22792534 | Diagnosis: gastric cancer with liver and peritoneal metastases. |
| PubMedID- 24575018 | These results inspired us to use intraperitoneal ptx for peritoneal metastases of gastric cancer, and we therefore designed a study involving intraperitoneal and intravenous ptx combined with oral s-1 chemotherapy. |
| PubMedID- 23457532 | Analysis of clinical tissue samples from peritoneal metastases arising from gastric cancers showed that runx3 expression decreased significantly in the metastatic tissue, compared to normal gastric mucosa or primary main tumors 8. |
| PubMedID- 24653620 | Intraperitoneal chemotherapy and its evolving role in management of gastric cancer with peritoneal metastases. |
| PubMedID- 21525806 | Due to the heterogeneous metastatic patterns (frequently including peritoneal metastases) of gastric cancer, the performance of a secondary metastatic resection with a curative intent appears to be clearly more difficult. |
| PubMedID- 21385469 | Us, eus, ct and 18f-fdg pet did not obtain consistently high sensitivity and specificity in assessing liver and peritoneal metastases of gastric cancer. |
| PubMedID- 24204159 | Patients with refractory peritoneal metastases of gastric cancer and symptomatic ascites resistant to systemic chemotherapy and intraperitoneal docetaxel were treated with single-agent bevacizumab. |
| PubMedID- 25173363 | Preferential her2 expression in liver metastases and egfr expression in peritoneal metastases in patients with advanced gastric cancer. |
| PubMedID- 25061539 | It remains unclear, however, whether this multimodal treatment protocol is also beneficial for signet-ring cell gastric cancer (src) patients with peritoneal metastases. |
| PubMedID- 22872745 | Methods: the medical records of 131 gastric cancer patients with peritoneal metastases who received intraperitoneal paclitaxel between 2005 and 2011 were retrospectively analyzed. |
| PubMedID- 25398590 | Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-ii clinical trial with a 40-month follow-up. |
| PubMedID- 24394055 | Case 2: a 62-year-old man examined for weight loss was diagnosed as having gastric cancer with peritoneal metastases. |
Page: 1